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Background: Smartphone-based applications to identify cardiac implantable electronic devices (CIED) are
extremely useful in circumstances, where urgent device interrogation is needed, and a device identification card
is not available. Few studies have provided insights regarding the utility of these applications. We have studied
two widely available applications i.e., Pacemaker ID app (PMIDa) or Cardiac Rhythm Management Device-Finder
(CRMD-f) to identify device manufacturers in CIEDs.
Methods: 547 patients who underwent CIED implantation from the year 2016–2020 in our institute were
enrolled. There were 438 Medtronic and 109 St. Jude’s devices. All chest radiographs were de-identified and
resized into 225*225 pixels focusing on the CIED. PMIDa and CRMD-f applications were used to identify the
CIED. Accuracy, sensitivity, specificity, negative predictive value, and positive predictive value for both appli
cations were calculated and compared.
Results: Overall, CRMD-f application has higher specificity (93.58 vs. 82.5%) but lower sensitivity (53.6 vs. 55%)
than PMIDa. The accuracy of both applications was comparable (61.6% vs. 60.5%). Accuracy varied with CIED
model and type tested, and radiograph projection used. Accuracy is greatest with Cardiac-ResynchronizationTherapy (CRT) devices for both applications, followed by a single lead pacemaker.
Conclusion: CRMD-f has higher accuracy and specificity for CIED manufacturer identification. Both PMIDa and
CRMD-f are specific tools to identify CIED but have low sensitivity.

1. Introduction
Cardiac implantable electronic devices (CIED) are increasingly being
implanted across the world. With an expansion in the number of CIED
implanted every year, physicians frequently encounter the need of de
vice interrogation [1]. Timely interrogation of CIED helps with quicker
diagnosis and management of patients with cardiovascular disease.
Furthermore, patients with CIED need device interrogation and changes
in the device parameters to safely perform emergency surgery. Emer
gency Department (ED) staff can now interrogate CIED with similar
interrogation time and have no impact on the length of ED stay and
similar 30-days outcomes when compared to the standard procedures of
interrogation in ED [2,3]. However, significant time is spent in

retrieving information about the device manufacturer from the medical
records in circumstances when the device identification card is not
available, which can potentially delay the necessary therapies for
certain arrhythmias or delay the emergency treatment required.
Smartphone-based applications like Pacemaker ID application
(PMIDa) and Cardiac Rhythm Management Device-Finder (CRMD-f)
have been designed to aid with quicker recognition of device manu
facturers so that manufacturer-specific equipment is arranged for the
device interrogation. Either of the two applications needs validation
studies to ascertain their usefulness in device manufacturer
identification.
PMIDa is a smartphone-based application that uses neural networkdriven model to recognize the device manufacturer (Fig. 1) [4]. It is also
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Manufacturer representation includes Medtronic 80.1% (438) and St.
Jude Medical 19.9% (109) of patients. The unequal distribution of the
device manufacturer was due to local availability and hospital contract
with the device manufacturer. All chest radiographs were de-identified.
Each X-ray was cropped and resized into 225*225 pixels. For every
CIED, manufacturer identification was attempted using PMIDa and
CRMD-f. The physician using both methods was blinded of the original
manufacturer. Sensitivity and specificity for both methods were
compared.
Analysis was performed using SPSS version 23. Descriptive analysis
was used to calculate respective frequencies. Cross-tabulation was used
for calculating individual accuracies, sensitivities, specificities, negative
predictive values (NPV), and positive predictive values (PPV). Accu
racies were separately calculated for individual model and device type.
For a PMIDa to detect manufacturer, a cut-off of 75% was used as a
prediction certainty. The answer was considered correct for the appli
cations if the answer matched the real manufacturer (known from
medical records).
The work has been reported in line with the STROCSS criteria [6].
The project has been registered with clinicaltrial.gov (UIN:
NCT04957108)
[7].
https://clinicaltrials.gov/ct2/show/NC
T04957108.
3. Results
A total of 547 CIED were analyzed. There were 368 dual-chamber
pacemakers, 122 single implantable cardioverter defibrillators (ICD), 7
single lead permanent pacemakers, and 15 Cardiac Resynchronization
Therapy (CRT) devices. Device models interrogated are as shown in
Table 1. Chest radiograph projection was anteroposterior in 87 (14.6%)
and posteroanterior in 460 devices (76.8%).
PMIDa sensitivity in identifying device manufacturers was 55% and
specificity was 82.5%. PMIDa negative predictive value (NPV) was 31%
and the positive predictive value (PPV) was 92.6%. CaRDIA-X algorithm
carried a sensitivity of 53.6% and specificity of 93.58% with an NPV of
33.4% and PPV of 97% (Table 2 and Fig. 4).
When compared to PMIDa, the accuracy of CRMD-f was lower for
Medtronic (56.6% vs. 57.9%) and higher for St. Jude Medical (94.4% vs.
75.2%). CRMD-f had 100% accuracy for single-lead PPM and CRTs.
PMIDa also correctly identified 100% of CRTs. PMIDa had higher ac
curacy with AP-projection when compared to PA-projection (72.4% vs.
59.3%), whereas CRMD-f had higher accuracy with PA-projection (98.5
vs. 94%). (Table 3).

Fig. 1. Pacemaker ID application user interface.

available as a website. CRMD-f is a mobile-based application that was
developed by Dr. Ines Sherifi and Tarun Kotia and includes a
flow-chart-based inspection of CIED using the CaRDIA-X algorithm
(Fig. 2). CaRDIA-X is Cardiac Rhythm Device Identification Algorithm
using X-rays. This algorithm utilizes the fact that every device has
certain unique radiographic and morphologic features such as the shape
of the battery, CAN, and header position concerning the battery, pres
ence of coils, etc., which can facilitate device identification [5] (Fig. 3).

4. Discussion
Cardiology staff on-call often gets called for urgent interrogation of
CIED. This entails consults from ED or peri-operative areas. Often, our
patients fail to show CIED identity cards in emergency situations. In such
circumstances, where urgent interrogation and programming of CIED
are needed and the manufacturer name and device type are not known,
either a PMIDa or CRMD-f with CaRDIA-X algorithm can be used to
identify the device manufacturer.
In this study, we have used CRMD-f mobile application instead of
manual CaRDIA-X flow-chart and compared it with PMIDa. Our study
points towards variability concerning the manufacturer, device type,
and X-ray projections used. Overall, CRMD-f had higher specificity
(93.58 vs. 82.5%) but relatively lower sensitivity (53.6 vs. 55%) than
PMIDa. We compared our sub-group accuracies to the one demonstrated
in Chudow et al. study and found the interpretations mentioned in
Table no. 3. In essence, when compared to the manual CaRDIA-X
flowchart used in Chudow et al. the CRMD-f application had greater
accuracy for St. Jude’s Medical and single lead ICDs whereas a lesser
accuracy for Medtronic CIED. Based on the device type, both the studies
reported lesser accuracy with PPM in comparison to ICDs.
Chudow et al. looked at the head-to-head comparison of the accuracy

2. Methods
This was a single-center, observational study approved by the Aga
Khan University Hospital Ethics Review Committee (ERC Number:
2020-5101-14156). The patient enrollment period ranged from 2015 to
2020. All subjects who underwent CIED implantation during this study
period and undergoing chest radiograph after the procedure at any time
were enrolled in the study. Chest radiographs were obtained from the
electronic medical record system of the hospital. Commonly used
manufacturers in the institute included Medtronic and St. Jude Medical.
Physicians using the applications were blinded to the manufacturer
and were pre-trained to use the applications on a set of 20 radiographs.
A single Nokia phone (13-megapixel camera) was used for all the de
vices. Screen resolution was 1366*768. Both anterior-posterior (AP) and
posterior-anterior projections (PA) were used.
547 CIED implanted from the year 2015–2020 were enrolled.
2
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Fig. 2. Cardiac Rhythm Management Device Finder application user interface.
Table 2
Sensitivity, specificity, and accuracy of Pacemaker ID app and CRMD-finder app.
Application

Sensitivity (%)

Specificity (%)

Accuracy (%)

PacemakerID
CRMD-Finder

55
53.6

82.5
93.58

60.5
61.6

Fig. 3. Radiographic parts of the cardiac implantable electronic device.
Table 1
Device models tested in the study.
Device Model

Number (n)

Percentage (%)

Medtronic PPM Sensia
Medtronic Evera S MRI ICD
Medtronic Bravaquard CRT-D
Medtronic Attesta PPM MRI
Medtronic Ensura DR MRI PPM
Abbot Fortify Assura
Others

89
30
17
4
265
27
115

14.9
5
2.8
0.7
44.2
4.5
21%

Fig. 4. Sensitivity, specificity, and accuracy of Pacemaker ID app and CRMDfinder app.

51%–100%). The manual CaRDIA-X flow-chart was reported to be timeconsuming and cumbersome when compared to PMIDa [8]. This
brought us to the testing of CRMD-f which is an application-based
CaRDIA-X flow-chart and allows quicker user interface and identifica
tion of the device. In comparison to Chudow et al. study, we demon
strated lesser sensitivity and specificity, pointing towards inter-study
variability.
The respective accuracies of our study and Chudow et al. for Med
tronic devices were: 57.9 vs. 96% (PMIDa) and 56.6 vs. 72% (CRMD-f vs.
manual CaRDIA-X flow chart). For pacemakers overall, the accuracies
were 52.5 vs. 83% (PMIDa) and 50.6 vs. 88% (CRMD-f vs. manual
CaRDIA-X flow chart). Both the studies individually demonstrated
relatively higher accuracy for ICD vs. PPM when using PMIDa (This

of various machine learning algorithms in identifying CIED. The study
used a manual CaRDIA-X flow-chart whereas our study used a mobile
phone application-based CaRDIA-X algorithm. Chudow et al. reported
an average accuracy of 88% for ICDs and 80% for PPMs with a vari
ability of 71–99% depending upon the manufacturer being tested.
Likewise, PMIDa had an overall accuracy of more than 75% (range:
3
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identification tools on patient outcomes in terms of time-to-diagnosis
and time-to-therapy has yet to be studied. We are planning to analyze
the difference in prognostic outcomes concerning different modalities
and applications used for device identification as our future project. We
will assess if efficient and timely device information results in better
management decisions for patients with CIED.

Table 3
- Comparison of our study with Chudow et al. demonstrating inter-study vari
ability of accuracies of PMIDa and CRMD-f.
Device
characteristic

PMIDa was
correct Shams
et al.

PMIDa
accuracy
Chudow
et al.

CRMD-Finder
was correct
Shams et al.

CaRDIA-X
accuracy
Chudow
et al.

Medtronic
St. Jude
Medical
Dual chamber
PPM
Single lead
PPM
CRT
Single lead
ICD
Anteriorposterior
projection
Posterioranterior
projection

57.9%
75.2%

96%
89%

56.6%
94.4%

72%
84%

52.1%

52.5%

49.7%

71.4%
100%
75.4%
72.4%
59.3%

50.6%

4.1. Study limitations

88%

Our study was a single-centered study, and we were limited by the
lack of availability of CIED manufacturers other than Medtronic and St.
Jude Medical. Prospective data on patient outcomes is lacking and needs
further research.

100%
95% (For
all ICDs)

100%
93.4%
94%

88% (For
all ICDs)

5. Conclusion
CRMD-f has higher accuracy and specificity for CIED manufacturer
identification. Both PMIDa and CRMD-f are specific tools to identify but
have lesser sensitivity. Accuracy is greatest with CRTs for both appli
cations, followed by single lead PPM. Both methods demonstrate vari
ability across the studies. Our study is one of the few studies testing AI
for CIED identification using chest radiograph and the first one from a
low-middle income country.

98.5%

study: 52.5 vs. 75.4% for PMIDa; Chudow et al.: 83% vs. 95%). The
inter-study variability for PMIDa can be explained by the difference in
mobile phone manufacturer and camera megapixel used in both the
studies (iPhone 8 12 megapixels versus Nokia 13 megapixels), the dif
ference in screen resolutions used, and the difference in projections
used. Additionally, differences in the extent of data augmentation (such
as flipping and cropping of radiograph images) can lead to variability.
The variability for CRMD-f or CaRDIA-X algorithm can be due to interphysician variability i.e., level of professional training. This aspect de
termines one’s familiarity with device identifiers on visual inspection of
the chest radiograph.
Additionally, our study concluded that for a machine-learning-based
application (PMIDa) AP projection yields greater accuracy (72.4% vs.
59.3%) whereas, for a flow-chart-based application, the PA projection
yields higher accuracy (98.5% vs. 94%). This is likely because PMIDa
involves taking picture of the device and an AP projection theoretically
magnifies anterior structures (including CIED).
The use of the CaRDIA-X algorithm is shown to have intra-operator
variability with the electrophysiologists showing best performance,
owing to their greater familiarity with devices and algorithms. An
accuracy-variability amongst physicians of 62.3%–88.9% has been re
ported [9]. In our study, CRMD-f was used by two cardiology
fellows-in-training (FIT) of the same professional year who were
pre-trained to grow familiarity with the radiographic anatomy of de
vices. Our study was limited by the fact that physicians interpreting the
radiographs were not of different professional levels. Our study is clin
ically applicable and in more correlation with the ground reality,
wherein emergency situations mostly cardiology FIT need to interrogate
the CIED.
The use of neural-network-based artificial intelligence (AI) for
identifying CIED is gaining attention. A single centered study compared
the network with that of cardiologists and found that neural networkbased AI performs better than the cardiologists to identify CIED
(99.6% vs. 72%) [9]. However, other studies [8,10] including ours show
variable accuracies pointing towards the variable performance of neural
networks. The difference in the accuracy of various neural network
methods can be explained by the difference in training sets and software
used for machine learning.
Despite the variable results, artificial intelligence maintains its
attraction due to its ease of use and quicker results. Importantly, like
with any technology, it might restrict cardiologists’ ability to manually
identify devices based on certain morphologic characteristics. CaRDIA-X
is superior to PMIDa in terms of output because it not only identifies the
device manufacturer but also the CIED type. The impact of these device
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